{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:37:42Z","timestamp":1792571862187,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T00:00:00Z","timestamp":1436745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.beem.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T07:02:24Z","timestamp":1436857344000},"page":"607-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":224,"title":["DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Jenifer P.","family":"Suntharalingham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Buonocore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Achermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2015.07.004_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.1700600220","article-title":"Addison's disease due to congenital adrenal hypoplasia of the adrenals in an infant aged 33 days","volume":"60","author":"Sikl","year":"1948","journal-title":"J\u00a0Pathol Bacteriol"},{"key":"10.1016\/j.beem.2015.07.004_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/372672a0","article-title":"Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism","volume":"372","author":"Muscatelli","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.beem.2015.07.004_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ng0894-497","article-title":"A\u00a0dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal","volume":"7","author":"Bardoni","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/372635a0","article-title":"An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita","volume":"372","author":"Zanaria","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.beem.2015.07.004_bib5","doi-asserted-by":"crossref","first-page":"18390","DOI":"10.1073\/pnas.0808936105","article-title":"The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1","volume":"105","author":"Sablin","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2015.07.004_bib6","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/MCB.17.3.1476","article-title":"DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita","volume":"17","author":"Ito","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.beem.2015.07.004_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/3822","article-title":"Role of Ahch in gonadal development and gametogenesis","volume":"20","author":"Yu","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib8","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/en.2010-0986","article-title":"Evidence of adrenal failure in aging Dax1-deficient mice","volume":"152","author":"Scheys","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2015.07.004_bib9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/me.2003-0159","article-title":"DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation","volume":"17","author":"Lalli","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2008-1064","article-title":"CBP\/p300-interacting transactivator, with Glu\/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease","volume":"94","author":"Ferraz-de-Souza","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib11","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/MCB.01010-08","article-title":"Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis","volume":"29","author":"Xu","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.beem.2015.07.004_bib12","first-page":"504","article-title":"Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita","volume":"84","author":"Reutens","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib13","first-page":"4501","article-title":"X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females","volume":"84","author":"Seminara","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/eje.1.02132","article-title":"DAX1 and X-linked adrenal hypoplasia congenita: clinical and molecular analysis in five patients","volume":"154","author":"Mantovani","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1515\/jpem-2001-0804","article-title":"Variable presentation of X-linked adrenal hypoplasia congenita","volume":"14","author":"Wiltshire","year":"2001","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2265.2009.03652.x","article-title":"Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations","volume":"72","author":"Landau","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2015.07.004_bib17","first-page":"4497","article-title":"Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay","volume":"84","author":"Achermann","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib18","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jcem.86.9.7816","article-title":"Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene","volume":"86","author":"Domenice","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI7212","article-title":"A\u00a0novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism","volume":"105","author":"Tabarin","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2015.07.004_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/jc.2002-021034","article-title":"An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita","volume":"88","author":"Ozisik","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jcem.87.1.8163","article-title":"Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita","volume":"87","author":"Mantovani","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0140-6736(10)61153-1","article-title":"Puberty, stress and sudden death","volume":"376","author":"Guclu","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2015.07.004_bib23","doi-asserted-by":"crossref","first-page":"K45","DOI":"10.1530\/EJE-12-1055","article-title":"A\u00a0man with a DAX1\/NR0B1 mutation, normal puberty, and an intact hypothalamic-pituitary-gonadal axis but deteriorating oligospermia during long-term follow-up","volume":"168","author":"Raffin-Sanson","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib24","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.fertnstert.2005.05.037","article-title":"Somatic mutational analysis of DAX1 in testes from men with idiopathic azoospermia","volume":"84","author":"Mantovani","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2015.07.004_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/jmg.2007.055129","article-title":"Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita","volume":"45","author":"Shaikh","year":"2008","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1067\/mpd.2000.108567","article-title":"Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1","volume":"137","author":"Achermann","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.07.004_bib27","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1210\/jc.2006-0603","article-title":"Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience","volume":"91","author":"Lin","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib28","first-page":"3171","article-title":"Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression","volume":"86","author":"Achermann","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/301782","article-title":"DAX1 mutations map to putative structural domains in a deduced three-dimensional model","volume":"62","author":"Zhang","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2005.12.004","article-title":"A\u00a0familial missense mutation in the hinge region of DAX1 associated with late-onset AHC in a prepubertal female","volume":"88","author":"Bernard","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/humrep\/deq372","article-title":"Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation","volume":"26","author":"Frapsauce","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.beem.2015.07.004_bib32","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/mend-5-10-1552","article-title":"A\u00a0shared promoter element regulates the expression of three steroidogenic enzymes","volume":"5","author":"Rice","year":"1991","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib33","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1016\/S0021-9258(19)37129-7","article-title":"A\u00a0common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s","volume":"267","author":"Morohashi","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2015.07.004_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0092-8674(94)90211-9","article-title":"A\u00a0cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation","volume":"77","author":"Luo","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.beem.2015.07.004_bib35","doi-asserted-by":"crossref","first-page":"31708","DOI":"10.1074\/jbc.M002892200","article-title":"A\u00a0naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes","volume":"275","author":"Ito","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2015.07.004_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1097-2765(00)80480-3","article-title":"Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress","volume":"3","author":"Hammer","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.beem.2015.07.004_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.devcel.2011.06.028","article-title":"Eliminating SF-1 (NR5A1) sumoylation in\u00a0vivo results in ectopic hedgehog signaling and disruption of endocrine development","volume":"21","author":"Lee","year":"2011","journal-title":"Dev Cell"},{"key":"10.1016\/j.beem.2015.07.004_bib38","doi-asserted-by":"crossref","first-page":"15054","DOI":"10.1073\/pnas.1416740111","article-title":"The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1","volume":"111","author":"Blind","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2015.07.004_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/aja.1002040104","article-title":"Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice","volume":"204","author":"Shinoda","year":"1995","journal-title":"Dev Dyn"},{"key":"10.1016\/j.beem.2015.07.004_bib40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/endo.143.2.8652","article-title":"Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity","volume":"143","author":"Majdic","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2015.07.004_bib41","doi-asserted-by":"crossref","first-page":"14488","DOI":"10.1073\/pnas.97.26.14488","article-title":"Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response","volume":"97","author":"Bland","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2015.07.004_bib42","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1095\/biolreprod.108.069435","article-title":"Impaired follicle development and infertility in female mice lacking steroidogenic factor 1 in ovarian granulosa cells","volume":"79","author":"Pelusi","year":"2008","journal-title":"Biol Reprod"},{"key":"10.1016\/j.beem.2015.07.004_bib43","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1096\/fj.10-170522","article-title":"ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland","volume":"25","author":"Ferraz-de-Souza","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.beem.2015.07.004_bib44","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1210\/jc.2010-2021","article-title":"Sterol O-acyltransferase 1 (SOAT1, ACAT) is a novel target of steroidogenic factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal","volume":"96","author":"Ferraz-de-Souza","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib45","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/ncomms4634","article-title":"Glycolytic genes are targets of the nuclear receptor Ad4BP\/SF-1","volume":"5","author":"Baba","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2015.07.004_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2012.11.005","article-title":"Beyond steroidogenesis: novel target genes for SF-1 discovered by genomics","volume":"371","author":"Lalli","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/9629","article-title":"A\u00a0mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans","volume":"22","author":"Achermann","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib48","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1210\/jcem.87.4.8376","article-title":"Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner","volume":"87","author":"Achermann","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib49","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/316893","article-title":"Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1\/SF-1) and adrenocortical insufficiency","volume":"67","author":"Biason-Lauber","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib50","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/jc.2003-031240","article-title":"A\u00a0microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency","volume":"89","author":"Correa","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1210\/jc.2006-1672","article-title":"Heterozygous missense mutations in steroidogenic factor 1 (SF1\/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function","volume":"92","author":"Lin","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/humu.20588","article-title":"Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency","volume":"29","author":"Kohler","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2015.07.004_bib53","doi-asserted-by":"crossref","first-page":"e24117","DOI":"10.1371\/journal.pone.0024117","article-title":"Mutation analysis of NR5A1 encoding steroidogenic factor 1 in 77 patients with 46,XY disorders of sex development (DSD) including hypospadias","volume":"6","author":"Allali","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.beem.2015.07.004_bib54","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1210\/jc.2007-0024","article-title":"Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome","volume":"92","author":"Coutant","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/cen.12012","article-title":"A\u00a0novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development","volume":"78","author":"Wu","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2015.07.004_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1530\/EJE-11-0392","article-title":"Pubertal androgenization and gonadal histology in two 46,XY adolescents with SF-1 mutations and predominantly female phenotype at birth","volume":"166","author":"Cools","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-11-0944","article-title":"Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations","volume":"167","author":"Tantawy","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib58","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI73186","article-title":"Testicular differentiation factor SF-1 is required for human spleen development","volume":"124","author":"Zangen","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2015.07.004_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1530\/EJE-09-0067","article-title":"The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency","volume":"161","author":"Kohler","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.07.004_bib60","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1093\/humrep\/dem278","article-title":"Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study","volume":"22","author":"Philibert","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.beem.2015.07.004_bib61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajhg.2010.09.009","article-title":"Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1","volume":"87","author":"Bashamboo","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib62","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ejhg.2012.290","article-title":"Comprehensive sequence analysis of the NR5A1 gene encoding steroidogenic factor 1 in a large group of infertile males","volume":"21","author":"R\u00f6pke","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.beem.2015.07.004_bib63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.fertnstert.2015.04.017","article-title":"Mutational screening of NR5A1 gene encoding steroidogenic factor 1 (SF-1) in cryptorchidism and male factor infertility and functional analysis of seven undescribed mutations","volume":"104","author":"Ferlin","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2015.07.004_bib64","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa0806228","article-title":"Mutations in NR5A1 associated with ovarian insufficiency","volume":"360","author":"Lourenco","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2015.07.004_bib65","doi-asserted-by":"crossref","first-page":"E1294","DOI":"10.1210\/jc.2011-3169","article-title":"Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals","volume":"97","author":"Camats","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.fertnstert.2011.10.032","article-title":"Limited contribution of NR5A1 (SF-1) mutations in women with primary ovarian insufficiency (POI)","volume":"97","author":"Janse","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2015.07.004_bib67","doi-asserted-by":"crossref","first-page":"E1017","DOI":"10.1210\/jc.2012-4111","article-title":"NR5A1 (SF-1) mutations are not a major cause of primary ovarian insufficiency","volume":"98","author":"Voican","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib68","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/jc.2009-2040","article-title":"Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults","volume":"95","author":"Almeida","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib69","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib70","first-page":"1746","article-title":"Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women","volume":"86","author":"Calvo","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.07.004_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000328821","article-title":"Partial deletion of the NR5A1 (SF1) gene detected by synthetic probe MLPA in a patient with XY gonadal disorder of sex development","volume":"5","author":"Barbaro","year":"2011","journal-title":"Sex Dev"},{"key":"10.1016\/j.beem.2015.07.004_bib72","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/ajmg.a.31685","article-title":"Ovotestes and XY sex reversal in a female with an interstitial 9q33.3-q34.1 deletion encompassing NR5A1 and LMX1B causing features of Genitopatellar syndrome","volume":"143A","author":"Schlaubitz","year":"2007","journal-title":"Am J Med Genet A"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X15000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X15000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:48:16Z","timestamp":1761497296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X15000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1521690X15000718"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2015.07.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}